Detection of a point mutation associated with high-level isoniazid resistance in Mycobacterium tuberculosis by using real-time PCR technology with 3′-minor groove binder-DNA probes

被引:40
作者
van Doorn, HR
Claas, ECJ
Templeton, KE
van der Zanden, AGM
Vije, ATK
de Jong, MD
Dankert, J
Kuijper, EJ
机构
[1] Acad Med Ctr, Dept Med Microbiol, NL-1100 DE Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Ctr Infect Dis, Leiden, Netherlands
[3] Gelre Hosp, Dept Med Microbiol, Apeldoorn, Netherlands
关键词
D O I
10.1128/JCM.41.10.4630-4635.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Tuberculosis remains one of the leading infectious causes of death worldwide. The emergence of drug-resistant strains of Mycobacterium tuberculosis is a serious public health threat. Resistance to isoniazid (INH) is the most prevalent form of resistance in M. tuberculosis and is mainly caused by mutations in the catalase peroxidase gene (katG). Among high-level INH-resistant isolates (MIC greater than or equal to 2), 89% are associated with a mutation at codon 315 of katG. There is a need to develop rapid diagnostic tests to permit appropriate antibiotic treatment and to improve clinical management. Therefore, a single-tube real-time PCR, using a novel kind of probe (3'-minor groove binder-DNA probe), was developed to detect either the wild-type or the mutant codon directly in Ziehl-Neelsen-positive sputum samples. The detection limit of the assay for purified DNA was 5 fg per well (one mycobacterial genome), and with spiked sputum samples, it was 20 copies per well, corresponding to 10(3) mycobacteria per ml of sputum. Sputum samples from 20 patients living in Kazakhstan or Moldova and infected with monodrug- or multidrug-resistant M. tuberculosis and 20 sputum samples from patients infected with INH-susceptible M. tuberculosis were tested. The sensitivities and specificities of the probes were 70 and 94% for the wild-type probe and 82 and 100% for the mutant probe. Binding to either probe was nonambiguous. This real-time PCR allows the rapid identification of a mutant katG allele and can easily be implemented in a clinical microbiology laboratory.
引用
收藏
页码:4630 / 4635
页数:6
相关论文
共 37 条
  • [1] Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG
    Abate G.
    Hoffner S.E.
    Miörner H.
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (5) : 329 - 333
  • [2] Ausubel FM., 1994, Curr. Protoc. Mol. Biol
  • [3] INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS
    BANERJEE, A
    DUBNAU, E
    QUEMARD, A
    BALASUBRAMANIAN, V
    UM, KS
    WILSON, T
    COLLINS, D
    DELISLE, G
    JACOBS, WR
    [J]. SCIENCE, 1994, 263 (5144) : 227 - 230
  • [4] BERSTEIN J, 1952, AM REV TUBERC, V65, P357
  • [5] RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS
    BOOM, R
    SOL, CJA
    SALIMANS, MMM
    JANSEN, CL
    WERTHEIMVANDILLEN, PME
    VANDERNOORDAA, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) : 495 - 503
  • [6] Global trends in resistance to antituberculosis drugs
    Espinal, MA
    Laszlo, A
    Simonsen, L
    Boulahbal, F
    Kim, SJ
    Reniero, A
    Hoffner, S
    Rieder, HL
    Binkin, N
    Dye, C
    Williams, R
    Raviglione, MC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) : 1294 - 1303
  • [7] THE EMERGENCE OF DRUG-RESISTANT TUBERCULOSIS IN NEW-YORK-CITY
    FRIEDEN, TR
    STERLING, T
    PABLOSMENDEZ, A
    KILBURN, JO
    CAUTHEN, GM
    DOOLEY, SW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) : 521 - 526
  • [8] Gangadharam P.R.J., 1984, DRUG RESISTANCE MYCO
  • [9] New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis
    Garcia de Viedma, D
    Infantes, MDD
    Lasala, F
    Chaves, F
    Alcalá, L
    Bouza, E
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) : 988 - 995
  • [10] Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa
    Haas, WH
    Schilke, K
    Brand, J
    Amthor, B
    Weyer, K
    Fourie, PB
    Bretzel, G
    StichtGroh, V
    Bremer, HJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) : 1601 - 1603